Quick Answer
Raphael Pharmaceutical Inc. reported Research And Development Expense of $631.0 thousand for the year ending 2025.
- Raphael Pharmaceutical Inc. showed a decrease of -18.7% in Research And Development Expense from 2024 to 2025.
- This data is from Raphael Pharmaceutical Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Raphael Pharmaceutical Inc.'s Research And Development Expense has grown by 36.9%.
- Historical annual values: Fiscal year 2025: $631.0 thousand | Fiscal year 2024: $776.0 thousand | Fiscal year 2023: $569.0 thousand | Fiscal year 2022: $1.18 million | Fiscal year 2021: $776.0 thousand | Fiscal year 2020: $461.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: